| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/29/2013 | EP2595989A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
| 05/29/2013 | EP2595656A1 Prevention and treatment of pain using monoclonal antibodies and antibody fragments to lysophosphatidic acid |
| 05/29/2013 | EP2595646A2 Bhlh proteins and their use as drugs |
| 05/29/2013 | EP2595644A1 Amyloid-beta clearance |
| 05/29/2013 | EP2595633A2 Methods of intravenous administration of glyburide and other drugs |
| 05/29/2013 | EP2595621A1 Treatment of l-dopa, dopamine agonist and/or dopamine enhancer induced disorders |
| 05/29/2013 | EP2595617A1 Topical treatment of neuropathic pain and methods of diagnosis |
| 05/29/2013 | EP2595615A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 05/29/2013 | CN1976934B Alkyl substituted indoloquinoxalines |
| 05/29/2013 | CN1911965B Binding domain-immunoglobulin fusion proteins |
| 05/29/2013 | CN1671643B Bipolar trans carotenoid salts and their uses |
| 05/29/2013 | CN1525866B Treatment using neublastin polypeptides |
| 05/29/2013 | CN103124742A Pharmaceutical compositions and methods of treatment |
| 05/29/2013 | CN103124741A Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
| 05/29/2013 | CN103124556A 贴剂 Patch |
| 05/29/2013 | CN103122019A Compounds useful for treating neurodegenerative disorders |
| 05/29/2013 | CN103122001A Polo-like kinase inhibitors |
| 05/29/2013 | CN103121998A Vinpocetine compound and drug composition thereof |
| 05/29/2013 | CN103121970A Benzimidazole and derivative thereof, and medicinal composition and application thereof in preparation of antidepressant medicaments |
| 05/29/2013 | CN103121969A Benzimidazole and derivative thereof, and medicinal composition and application thereof |
| 05/29/2013 | CN103120789A Traditional Chinese medicine composition for treating migraine |
| 05/29/2013 | CN103120788A Medicine for treating epilepsy and preparation method thereof |
| 05/29/2013 | CN103120787A Traditional Chinese medicine composition for treating decubation of schizophrenia and preparation method thereof |
| 05/29/2013 | CN103120786A Chinese medicinal preparation for treating schizophrenia |
| 05/29/2013 | CN103120765A Traditional Chinese medicine decoction for treating tremor syndrome |
| 05/29/2013 | CN103120763A Medicinal composition for treating sequela of cerebral apoplexy |
| 05/29/2013 | CN103120759A Supercritical extraction method of conic gymnadenia tuber element |
| 05/29/2013 | CN103120756A Compound essential oil capable of improving sleep of pregnant women |
| 05/29/2013 | CN103120751A Traditional Chinese medicine composition for treating insomnia |
| 05/29/2013 | CN103120744A Chinese medicinal composition for removing abnormal phlegm and preparation method thereof |
| 05/29/2013 | CN103120735A Medicinal composition for treating cerebral apoplexy hemiplegia |
| 05/29/2013 | CN103120731A Quick-acting migraine relieving powder and preparation method thereof |
| 05/29/2013 | CN103120694A Application of Gypensapogenin B in antidepressant drug |
| 05/29/2013 | CN103120688A Pharmaceutical composition of flash release preparation |
| 05/29/2013 | CN103120659A Application of Eryngiolide A in antidepressant drug |
| 05/29/2013 | CN103120656A Danshinolic acid A tablet and application thereof for preparing medicines |
| 05/29/2013 | CN103120649A Application of salvianolic acid freeze-dried powder injection for preparing medicine for inhibiting brain neuron damage or death |
| 05/29/2013 | CN103120643A Curcumin dicaprate suspension injection and preparation method and application thereof |
| 05/29/2013 | CN103120509A Drug pillow |
| 05/29/2013 | CN102626390B Gastrodin multiphase liposome injection |
| 05/29/2013 | CN102492022B Novel anti-senile dementia lead compound |
| 05/29/2013 | CN102293953B Ovientvine, chrysanthemum and stiff silkworm decoction for treating idiopathic facial palsy |
| 05/29/2013 | CN102267999B Flumazenil compound and preparation method thereof |
| 05/29/2013 | CN102151336B Active targeting drug conveying system for crossing blood brain barrier through mediation of acetylcholine receptor |
| 05/29/2013 | CN102050801B Method for preparing arylpiperazines derivative optical isomer |
| 05/29/2013 | CN101970429B 2-amino-quinoline derivatives useful as inhibitors of beta-secretase (bace) |
| 05/29/2013 | CN101925355B Fentanyl-containing patch for external use |
| 05/29/2013 | CN101891706B 3,4-dihydrobenzo[f][1,4]thiazepine compound or salts of same and medical use of same |
| 05/29/2013 | CN101693714B Spirocyclic cyclohexane derivatives |
| 05/29/2013 | CN101622254B Salts of 3-(3-amino-2-(r)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl)-1,3,8-triaza-spiro[4.5]decan-4-one |
| 05/29/2013 | CN101616669B Preparation of medicine for the treatment of alcohol abuse, addiction and dependency |
| 05/29/2013 | CN101553491B Quinoxaline derivative |
| 05/29/2013 | CN101538218B Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 05/29/2013 | CN101506145B Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 05/29/2013 | CN101485796B Chinese medicinal composition for treating insomnia as well as preparation method thereof |
| 05/29/2013 | CN101434593B Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof |
| 05/29/2013 | CN101429185B Two-crystal type of substance of meletin, production method, medicament composition and uses thereof |
| 05/29/2013 | CN101417081B Quality detection method of Longfengbao capsule |
| 05/29/2013 | CN101374863B Immunoglobulins directed against NOGO |
| 05/29/2013 | CN101090902B Cgrp受体拮抗剂 Cgrp receptor antagonist |
| 05/28/2013 | US8450347 Administering a protein fraction, digestible carbohydrates, and a combination of folate, and one of vitamin B6 and vitamin B12. |
| 05/28/2013 | US8450331 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
| 05/28/2013 | US8450306 Bradykinin B1-receptor antagonists |
| 05/28/2013 | CA2740262C 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
| 05/28/2013 | CA2739883C Cyclohexane derivative and pharmaceutical use thereof |
| 05/28/2013 | CA2727722C Use of dihydroimidazolones for the treatment of anxiety in dogs |
| 05/28/2013 | CA2714295C Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/28/2013 | CA2685447C Pharmaceutical composition |
| 05/28/2013 | CA2579807C Composition with preventive or improvement effect on symptoms or diseases associated with stress-induced behavior disorders |
| 05/28/2013 | CA2561897C Thio-substituted biaryl-methanesulfinyl derivatives |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2514794C Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2473970C Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/28/2013 | CA2455100C Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 05/28/2013 | CA2427661C Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/28/2013 | CA2381468C Percutaneous absorption preparations containing melatonin receptor agonist for percutaneous treatment of sleep disorders |
| 05/23/2013 | WO2013074986A1 Inhibitors of c-jun-n-terminal kinase (jnk) |
| 05/23/2013 | WO2013074798A1 Apoaequorin for reducing neuronal injury due to ischemia |
| 05/23/2013 | WO2013073577A1 Dihydroxy aromatic heterocyclic compound |
| 05/23/2013 | WO2013072758A1 Pyrimidine diol amides as sodium channel blockers |
| 05/23/2013 | WO2013072705A1 Muscarinic m1 receptor agonists |
| 05/23/2013 | WO2013072520A1 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 05/23/2013 | WO2013072328A1 Use of telaprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases |
| 05/23/2013 | WO2013072062A1 Composition for transdermal administration of rivastigmine |
| 05/23/2013 | WO2013071715A1 Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments |
| 05/23/2013 | WO2013071440A1 Methods and products for increasing frataxin levels and uses thereof |
| 05/23/2013 | WO2013071421A1 Pharmaceutical composition of amphetamine mixed salts |
| 05/23/2013 | WO2013071418A1 Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof |
| 05/23/2013 | WO2013049026A3 Neurabin scaffolding of the adenosine receptor and rgs4 regulates anti-seizure effect of endogenous adenosine |
| 05/23/2013 | WO2013042943A9 Use for glycolipoprotein gintonin, isolated and identified from ginseng, as a natural medicinal-plant-derived ligand |
| 05/23/2013 | WO2013040535A3 Bicarbocyclic and tricarbocyclic ethynyl derivatives and uses of same |
| 05/23/2013 | WO2013024492A3 A process for the preparation of asenapine and novel salts thereof |
| 05/23/2013 | US20130131038 N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | CA2856291A1 Inhibitors of c-jun-n-terminal kinase (jnk) |
| 05/23/2013 | CA2856076A1 Muscarinic m1 receptor agonists |
| 05/23/2013 | CA2855719A1 Apoaequorin for reducing neuronal injury due to ischemia |
| 05/23/2013 | CA2855653A1 Methods and products for increasing frataxin levels and uses thereof |